|
HY-13690-500mg
|
MedChemexpress LLC
|
Mitotane [CAS 53-19-0]
|
|
Cancer-programmed cell death
|
|
|
HY-13690-1mL
|
MedChemexpress LLC
|
Mitotane [CAS 53-19-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-13690S1-1mg
|
MedChemexpress LLC
|
Mitotane-13C6 [CAS 1261396-21-7]
|
|
Cancer-programmed cell death
|
|
|
HY-17543-10mg
|
MedChemexpress LLC
|
ML-323 [CAS 1572414-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-17543-100mg
|
MedChemexpress LLC
|
ML-323 [CAS 1572414-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-17543-5mg
|
MedChemexpress LLC
|
ML-323 [CAS 1572414-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-17543-50mg
|
MedChemexpress LLC
|
ML-323 [CAS 1572414-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-17543-1mL
|
MedChemexpress LLC
|
ML-323 [CAS 1572414-83-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-120348-10mg
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120348-100mg
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120348-25mg
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120348-5mg
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120348-50mg
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120348-1mL
|
MedChemexpress LLC
|
ML67-33 [CAS 1443290-89-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P73296-10ug
|
MedChemexpress LLC
|
MMP-2, Human (HEK293)
|
|
|
|
|
HY-P73296-100ug
|
MedChemexpress LLC
|
MMP-2, Human (HEK293)
|
|
|
|
|
HY-P73296-20ug
|
MedChemexpress LLC
|
MMP-2, Human (HEK293)
|
|
|
|
|
HY-P73296-5ug
|
MedChemexpress LLC
|
MMP-2, Human (HEK293)
|
|
|
|
|
HY-P73296-50ug
|
MedChemexpress LLC
|
MMP-2, Human (HEK293)
|
|
|
|
